ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1555062

Druggable proteins of Alistipes reveal promising antimicrobial targets against chronic intestinal inflammation

Provisionally accepted
Saman  SohailSaman Sohail1Ayesha  WisalAyesha Wisal1Sobia  RanaSobia Rana2Abid Khan -  Rao MuhammadAbid Khan - Rao Muhammad3Asad  UllahAsad Ullah1Farooq-Ahmad  KhanFarooq-Ahmad Khan4Muhammad  IrfanMuhammad Irfan2Muhammad  ImranMuhammad Imran5*Carvalho,  P.V.S.DCarvalho, P.V.S.D6*Renato  RozentalRenato Rozental6*Farzana  ShaheenFarzana Shaheen2,4*Hassan  Syed ShahHassan Syed Shah2*
  • 1Department of Chemistry, Islamia College University, Peshawar, Khyber Pakhtunkhwa, Pakistan
  • 2Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences , University of Karachi, Karachi, Pakistan
  • 3Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan
  • 4Hussain Ebrahim Jamal Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Punjab, Pakistan
  • 5Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia
  • 6Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil

The final, formatted version of the article will be published soon.

The genus Alistipes consists of anaerobic, gram-negative bacteria with 13 species that colonize the entire gastrointestinal tract and are a serious health concern. They contribute to gut dysbiosis, intestinal inflammation, colorectal cancer, and depression. To explore potential therapeutic targets and inhibitors, we filtered the core genome of Alistipes strains through subtractive genomics for non-host homology, gene essentiality, PPI, KEGG pathways, virulence, cellular localization, and druggability. The potential targets were docked against two drug-like libraries (ZINC, n = 11,993) and TCM (n = 36,043). ADMET profiling for best hits and MD simulation for apo/complex structures were performed, followed by physicochemical and pharmacokinetic evaluation and complex stabilities. A set of 39 potential proteins was drastically reduced to only two targets after sequential data mining. The 3D structures of the selected targets (LpxA and KdsB) revealed good druggability scores. The top hits (ZINC85530940, ZINC05161112, ZINC95911713, and ZINC05566415) for both targets showed maximum H-bond interactions. The RMSD and RMSF values exhibited compactness with minimum fluctuation in ligand-bound complexes. The β-factor of ZINC05161112 at 327 th residue and 352 nd residue exhibited higher thermal instability, consistent with the RMSF results. The globularity of the complexes and apo structures remained consistent, whereas the LpxA complexes exhibited lower solvent-accessible surface area. For the KdsB, the surface area for ZINC5566415 increased significantly, with a steep decrease for ZINC95911713, establishing rather stable protein-ligand complexes. The results highlight the importance of identifying novel inhibitors and therapeutic targets. They are crucial for establishing better treatment regimes for human health and to aid in controlling the pathogenicity of Alistipes species.

Keywords: Font: (Default) Times New Roman Font: (Default) Times New Roman Alistipes genera, Subtractive genomics, Druggable targets, TCM / ZINC inhibitors, pharmacokinetics, 10, e0121216. GASTEIGER, E.

Received: 12 Jan 2025; Accepted: 31 Mar 2025.

Copyright: © 2025 Sohail, Wisal, Rana, Rao Muhammad, Ullah, Khan, Irfan, Imran, P.V.S.D, Rozental, Shaheen and Syed Shah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Muhammad Imran, Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia
Carvalho, P.V.S.D, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, 4036, Rio de Janeiro, Brazil
Renato Rozental, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, 4036, Rio de Janeiro, Brazil
Farzana Shaheen, Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences , University of Karachi, Karachi, Pakistan
Hassan Syed Shah, Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences , University of Karachi, Karachi, Pakistan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more